NET PROFIT (x1000 NOK)
EMPLOYEES
Glucox Biotech AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-1,721
|
-1,340
|
-1,211 |
EBITDA |
-736
|
-654
|
-721 |
Total assets |
6,884
|
2,824
|
2,820 |
Current assets |
402
|
204
|
740 |
Current liabilities |
251
|
254
|
57 |
Equity capital |
-1,755
|
-31
|
1,350 |
- share capital |
1,573
|
1,469
|
1,515 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
-25.5%
|
-1.1%
|
47.9% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-25.0%
|
-47.5%
|
-42.9% |
Current ratio |
160.2%
|
80.3%
|
1298.2% |
Return on equity (ROE) |
98.1%
|
4322.6%
|
-89.7% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.